POVAGS: Post-Operative Voiding After Gynecological Surgery Trial

Sponsor
Women's College Hospital (Other)
Overall Status
Terminated
CT.gov ID
NCT04198285
Collaborator
(none)
42
1
2
3.5
11.8

Study Details

Study Description

Brief Summary

To determine whether partially filling the bladder after outpatient gynaecological laparoscopy expedites time to first void and discharge. Methods: A single site, single-blinded, randomized control trial in which eligible patients undergo partial retrograde bladder filling immediately post-operatively compared to bladder drainage and foley catheter removal. Primary outcome is time to first void, secondary outcomes include time to discharge, post-operative complications and patient satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Retrograde bladder filling
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
42 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Post-Operative Voiding After Gynecological Surgery (POVAGS) Trial: a Randomized Controlled Trial on Retrograde Bladder Filling After Outpatient Gynaecological Laparoscopy
Actual Study Start Date :
Jan 10, 2020
Actual Primary Completion Date :
Apr 27, 2020
Actual Study Completion Date :
Apr 27, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Retrograde filled

This arm will contain patients who had retrograde bladder filling upon completion of surgery with 200 milliliters (mL) of sterile saline.

Procedure: Retrograde bladder filling
The bladder will be filled with a large syringe through the urinary catheter (which is left in place for the surgery) with 200mL of sterile saline, and then the catheter will be removed.

No Intervention: Control

This arm will contain patients who simply had the urinary catheter removed upon completion of surgery, and were left with an empty bladder.

Outcome Measures

Primary Outcome Measures

  1. Time to first void [3 hours]

    Time in minutes from arrival in post-operative anesthesia unit (PACU) to first void

Secondary Outcome Measures

  1. Time to discharge [8 hours]

    Time in minutes from arrival in PACU to discharge from PACU

  2. Post-operative complications [1 week following surgery]

    Urinary tract infections, or other reported complications

  3. Patient satisfaction [1 week]

    Patients' subjective experience in both groups regarding time spent in PACU and first postoperative week

  4. Post-operative pain [Assessed at the 1 hour mark]

    visual analogue scale of postoperative pain, assessed in PACU

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women

  • Undergoing elective laparoscopy for a gynaecological indication

  • Plan for same day discharge

  • Able to provide informed consent

Exclusion Criteria:
  • Pregnancy

  • Undergoing procedure for pelvic organ prolapse, stress urinary incontinence, or nerve detrapment

  • Prior hysterectomy, or incontinence/pelvic organ prolapse procedures

  • Pre-existing voiding dysfunction

  • Known recurrent urinary tract infections

  • Known genito-urinary malformations

  • Known for neuromuscular disorders such as multiple sclerosis

  • Use of anticholinergic medication

  • Intraoperative bladder related complications

  • Need for discharge with indwelling foley catheter

  • Patients requiring overnight admission for any reason

Contacts and Locations

Locations

Site City State Country Postal Code
1 Women's College Hospital Toronto Ontario Canada M5S 1B2

Sponsors and Collaborators

  • Women's College Hospital

Investigators

  • Principal Investigator: Ally Murji, MD, Women's College Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jonathon Solnik, Site Chief of Gynecology, Women's College Hospital
ClinicalTrials.gov Identifier:
NCT04198285
Other Study ID Numbers:
  • 2019-0110-E
First Posted:
Dec 13, 2019
Last Update Posted:
Aug 18, 2020
Last Verified:
Aug 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jonathon Solnik, Site Chief of Gynecology, Women's College Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 18, 2020